Universe Pharmaceuticals (UPC) Equity Ratio: 2020-2024
- Universe Pharmaceuticals' Equity Ratio fell 0.11% to 0.67 in Q3 2024 from the same period last year, while for Sep 2024 it was 0.67, marking a year-over-year decrease of 0.11%. This contributed to the annual value of 0.67 for FY2024, which is 0.11% down from last year.
- As of Q3 2024, Universe Pharmaceuticals' Equity Ratio stood at 0.67, which was up 13.05% from 0.59 recorded in Q1 2024.
- Over the past 5 years, Universe Pharmaceuticals' Equity Ratio peaked at 0.86 during Q1 2022, and registered a low of 0.59 during Q1 2024.
- In the last 3 years, Universe Pharmaceuticals' Equity Ratio had a median value of 0.67 in 2023 and averaged 0.68.
- Over the last 5 years, Universe Pharmaceuticals' Equity Ratio had its largest YoY gain of 12.97% in 2023, and its largest YoY loss of 21.85% in 2023.
- Quarterly analysis of 5 years shows Universe Pharmaceuticals' Equity Ratio stood at 0.72 in 2020, then dropped by 7.24% to 0.67 in 2021, then dropped by 11.43% to 0.59 in 2022, then rose by 12.97% to 0.67 in 2023, then dropped by 0.11% to 0.67 in 2024.
- Its Equity Ratio stands at 0.67 for Q3 2024, versus 0.59 for Q1 2024 and 0.67 for Q3 2023.
